Edition:
United Kingdom

Kalvista Pharmaceuticals Inc (KALV.OQ)

KALV.OQ on NASDAQ Stock Exchange Global Market

9.51USD
15 Dec 2017
Change (% chg)

$0.30 (+3.26%)
Prev Close
$9.21
Open
$9.21
Day's High
$9.76
Day's Low
$9.21
Volume
54,719
Avg. Vol
32,308
52-wk High
$15.75
52-wk Low
$5.48

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Richard Aldrich

63 2016 Chairman of the Board

Thomas Crockett

42 2016 Chief Executive Officer, Director

Benjamin Palleiko

51 2016 Chief Financial Officer

Christopher Yea

53 2016 Chief Development Officer

Arnold Oronsky

77 2016 Director